Article info

Download PDFPDF
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

Authors

  • C P Bearcroft aDigestive Diseases Research Centre and St Bartholomew’s and the Royal London School of Medicine and Dentistry, Turner Street, London E1 2AD, UK, bDepartment of Medicine, St Bartholomew’s and the Royal London School of Medicine and Dentistry PubMed articlesGoogle scholar articles
  • D Perrett aDigestive Diseases Research Centre and St Bartholomew’s and the Royal London School of Medicine and Dentistry, Turner Street, London E1 2AD, UK, bDepartment of Medicine, St Bartholomew’s and the Royal London School of Medicine and Dentistry PubMed articlesGoogle scholar articles
  • M J G Farthing aDigestive Diseases Research Centre and St Bartholomew’s and the Royal London School of Medicine and Dentistry, Turner Street, London E1 2AD, UK, bDepartment of Medicine, St Bartholomew’s and the Royal London School of Medicine and Dentistry PubMed articlesGoogle scholar articles
  1. Dr Bearcroft.
View Full Text

Citation

Bearcroft CP, Perrett D, Farthing MJG
Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

Publication history

  • Accepted July 31, 1997
  • First published January 1, 1998.
Online issue publication 
February 14, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.